Factors Associated with CKD among Middle Age and Elderly Populations with T2DM and Hypertension in Thailand

Chalobon Treesak, Wongsa Laohasiriwong, Chutikan Sakphisutthikul

Abstract

This study analyzed the risk factors of chronic kidney disease (CKD) among middle-age and elderly populations with Type 2 Diabetes Mellitus (T2DM) and hypertension and its associated factors in Thailand. The cross-sectional study used the data from the records of 43 standard healthcare folders of the Heath Data Center (HDC) of the Ministry of Public Health (MoPH) with population of 19,342,297. The inclusion criteria included people aged > 45 with complete comorbidity data. 3,957,040 respondents passed the requirements and had processed for analysis. The multivariable analysis was used to analyze the factors associated with CKD when controlling for the effect of other covariates. The prevalence of CKD among middle-age and elderly populations with comorbidities was 4.97%. The multivariable analysis in the adjusted model indicated that factors that were associated with CKD included age ≥80 years (ORadj: 9.40, 95% CI: 8.51–10.38), being female (1.03, 1.01–1.07), and being comorbidity (6.69, 6.47–6.92). There is an urgent need for screening attempts to avoid early detection and improved practice for managing T2DM, hypertension, and CKD in the T2DM population in Thailand.

 

Keywords: chronic kidney disease, type 2 diabetes mellitus, hypertension.

 

https://doi.org/10.55463/issn.1674-2974.50.3.21


Full Text:

PDF


References


LUYCKX V. A., RULE A. D., TUTTLE K. R., DELANAYE P., LIAPIS H., GANDJOUR A., ROMAGNANI P., and ANDERS H.-J. Nephron overload as a therapeutic target to maximize kidney lifespan. Nature Reviews Nephrology, 2022, 18: 171–183. https://doi.org/10.1038/s41581-021-00510-7

LIM L. L., CHOW E., and CHAN J. C. N. Cardiorenal diseases in type 2 diabetes mellitus: clinical trials and real-world practice. Nature Reviews Endocrinology, 2023, 19: 151–163. https://doi.org/10.1038/s41574-022-00776-2

MELINO S., LEO S., and TOSKA PAPAJANI V. Natural Hydrogen Sulfide Donors from Allium sp. as a Nutraceutical Approach in Type 2 Diabetes Prevention and Therapy. Nutrients, 2019, 11(7): 1581. https://doi.org/10.3390/nu11071581

POLCYN J., VOUMIK L. C., RIDWAN M., RAY S., and VOVK V. Evaluating the Influences of Health Expenditure, Energy Consumption, and Environmental Pollution on Life Expectancy in Asia. International Journal of Environmental Research and Public Health, 2023, 20(5): 4000. https://doi.org/10.3390/ijerph20054000

GÜLÜMSEK E., & KEŞKEK Ş. Ö. Direct medical cost of nephropathy in patients with type 2 diabetes. International Urology and Nephrology, 2022, 54: 1383–1389. https://doi.org/10.1007/s11255-021-03012-4

WANG Y., YANG Y., and HE F. Insights into Concomitant Atrial Fibrillation and Chronic Kidney Disease. Reviews in Cardiovascular Medicine, 2022, 23(3): 105. https://doi.org/10.31083/j.rcm2303105

FITIPALDI H., & FRANKS P. W. Ethnic, gender and other sociodemographic biases in genome-wide association studies for the most burdensome non-communicable diseases: 2005–2022. Human Molecular Genetics, 2023, 32(1): 520–532. https://doi.org/10.1093/hmg/ddac245

GRANT C. H., SALIM E., LEES J. S., and STEVENS K. I. Deprivation and chronic kidney disease – a review of the evidence. Clinical Kidney Journal, 2023, 0(0): 1-11. https://doi.org/10.1093/ckj/sfad028

LAW J. P., PICKUP L., PAVLOVIC D., TOWNEND J. N., and FERRO C. J. Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations. Journal of Human Hypertension, 2023, 37: 1–19. https://doi.org/10.1038/s41371-022-00751-4

KANEKO T., KODANI E., FUJII H., NAKAMURA H., SASABE H, TAMURA Y., and TSURUOKA S. Medical and Dental Visits of Chronic Kidney Disease-Diagnosed Participants Analyzed from the Specific Health Checkups Results in Japan: TAMA MED Project-CKD. Journal of Clinical Medicine Research, 2020, 12(2): 115-121. http://doi.org/10.14740/jocmr4085

SHAYAKUL C., TEERABOONCHAIKUL R., SUSOMBOON T., KULABUSAYA B., and PUDCHAKAN P. Medication Adherence, Complementary Medicine Usage and Progression of Diabetic Chronic Kidney Disease in Thais. Patient Preference and Adherence, 2022, 16: 467-477. http://doi.org/10.2147/PPA.S350867

ADEGHATE E. A., KALÁSZ H., AL JABERI S., ADEGHATE J., and TEKES K. Tackling type 2 diabetes-associated cardiovascular and renal comorbidities: a key challenge for drug development. Expert Opinion on Investigational Drugs, 2021, 30(2): 85-93. http://doi.org/10.1080/13543784.2021.1865914

JITRAKNATEE J., RUENGORN C., and NOCHAIWONG S. Prevalence and Risk Factors of Chronic Kidney Disease among Type 2 Diabetes Patients: A Cross-Sectional Study in Primary Care Practice. Scientific Reports, 2020, 10: 6205. https://doi.org/10.1038/s41598-020-63443-4

DOBREK L. An Outline of Renal Artery Stenosis Pathophysiology — A Narrative Review. Life, 2021, 11(3): 208. https://doi.org/10.3390/life11030208.


Refbacks

  • There are currently no refbacks.